These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35893231)

  • 41. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
    Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
    EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The FibromiR miR-214-3p Is Upregulated in Duchenne Muscular Dystrophy and Promotes Differentiation of Human Fibro-Adipogenic Muscle Progenitors.
    Arrighi N; Moratal C; Savary G; Fassy J; Nottet N; Pons N; Clément N; Fellah S; Larrue R; Magnone V; Lebrigand K; Pottier N; Dechesne C; Vassaux G; Dani C; Peraldi P; Mari B
    Cells; 2021 Jul; 10(7):. PubMed ID: 34360002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A web-accessible complete transcriptome of normal human and DMD muscle.
    Bakay M; Zhao P; Chen J; Hoffman EP
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S125-41. PubMed ID: 12206807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR2Pathway: A novel analytical method to discover MicroRNA-mediated dysregulated pathways involved in hepatocellular carcinoma.
    Li C; Dinu V
    J Biomed Inform; 2018 May; 81():31-40. PubMed ID: 29578099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA and Alternative mRNA Splicing Events in Cancer Drug Response/Resistance: Potent Therapeutic Targets.
    Marima R; Francies FZ; Hull R; Molefi T; Oyomno M; Khanyile R; Mbatha S; Mabongo M; Owen Bates D; Dlamini Z
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle.
    Ebrahimi M; Lad H; Fusto A; Tiper Y; Datye A; Nguyen CT; Jacques E; Moyle LA; Nguyen T; Musgrave B; Chávez-Madero C; Bigot A; Chen C; Turner S; Stewart BA; Pegoraro E; Vitiello L; Gilbert PM
    Acta Biomater; 2021 Sep; 132():227-244. PubMed ID: 34048976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Duchenne muscular dystrophy gene and cancer.
    Jones L; Naidoo M; Machado LR; Anthony K
    Cell Oncol (Dordr); 2021 Feb; 44(1):19-32. PubMed ID: 33188621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype.
    Vieira NM; Elvers I; Alexander MS; Moreira YB; Eran A; Gomes JP; Marshall JL; Karlsson EK; Verjovski-Almeida S; Lindblad-Toh K; Kunkel LM; Zatz M
    Cell; 2015 Nov; 163(5):1204-1213. PubMed ID: 26582133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transcriptomic Analysis Reveals Involvement of the Macrophage Migration Inhibitory Factor Gene Network in Duchenne Muscular Dystrophy.
    Lombardo SD; Mazzon E; Mangano K; Basile MS; Cavalli E; Mammana S; Fagone P; Nicoletti F; Petralia MC
    Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31752120
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    Reyngoudt H; Turk S; Carlier PG
    NMR Biomed; 2018 Jan; 31(1):. PubMed ID: 29130550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive RNA-Sequencing Analysis in Serum and Muscle Reveals Novel Small RNA Signatures with Biomarker Potential for DMD.
    Coenen-Stass AML; Sork H; Gatto S; Godfrey C; Bhomra A; Krjutškov K; Hart JR; Westholm JO; O'Donovan L; Roos A; Lochmüller H; Puri PL; El Andaloussi S; Wood MJA; Roberts TC
    Mol Ther Nucleic Acids; 2018 Dec; 13():1-15. PubMed ID: 30219269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reliability and validity of the Thai version of the Pediatric Quality of Life inventory™ 3.0 Duchenne Muscular Dystrophy module in Thai children with Duchenne Muscular Dystrophy.
    Thongsing A; Likasitwattanakul S; Sanmaneechai O
    Health Qual Life Outcomes; 2019 May; 17(1):76. PubMed ID: 31046775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dysregulated mechanisms underlying Duchenne muscular dystrophy from co-expression network preservation analysis.
    Mukund K; Subramaniam S
    BMC Res Notes; 2015 May; 8():182. PubMed ID: 25935398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.
    Lin B; Li Y; Han L; Kaplan AD; Ao Y; Kalra S; Bett GC; Rasmusson RL; Denning C; Yang L
    Dis Model Mech; 2015 May; 8(5):457-66. PubMed ID: 25791035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulatory Mechanism of MicroRNA Expression in Cancer.
    Ali Syeda Z; Langden SSS; Munkhzul C; Lee M; Song SJ
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138313
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-Associated Salivary MicroRNA Biomarkers for Oculopharyngeal Muscular Dystrophy.
    Raz V; Kroon RHMJM; Mei H; Riaz M; Buermans H; Lassche S; Horlings C; Swart B; Kalf J; Harish P; Vissing J; Kielbasa S; van Engelen BGM
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.
    Trifunov S; Natera-de Benito D; Exposito Escudero JM; Ortez C; Medina J; Cuadras D; Badosa C; Carrera L; Nascimento A; Jimenez-Mallebrera C
    Front Neurol; 2020; 11():304. PubMed ID: 32373058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating miR-155-5p as a Novel Biomarker of Lumbar Degenerative Disc Disease.
    Divi SN; Markova DZ; Fang T; Guzek R; Kurd MF; Rihn JA; Hilibrand AS; Anderson DG; Vaccaro AR; Schroeder GD; Kepler CK
    Spine (Phila Pa 1976); 2020 May; 45(9):E499-E507. PubMed ID: 31770330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Massive analysis of cDNA Ends (MACE) and miRNA expression profiling identifies proatherogenic pathways in chronic kidney disease.
    Zawada AM; Rogacev KS; Müller S; Rotter B; Winter P; Fliser D; Heine GH
    Epigenetics; 2014 Jan; 9(1):161-72. PubMed ID: 24184689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High resolution NMR based analysis of serum lipids in Duchenne muscular dystrophy patients and its possible diagnostic significance.
    Srivastava NK; Pradhan S; Mittal B; Gowda GA
    NMR Biomed; 2010 Jan; 23(1):13-22. PubMed ID: 19787747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.